Form 4 for RMD ResMed|
Accepted 2024-08-16 00:00:00 ET · period of report 2024-08-16 · accession 0001127602-24-022294 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-08-16 | 2024-08-15 | RMD | Farrell Michael J. | CEO | A - Grant | $0.00 | +23.4K | 464.2K | +5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2024-08-15 | A | A | 19,272 | $0.00 | 460,071 | D | — | — | |
| 2 | Common | ResMed Common Stock | 2024-08-15 | A | A | 4,098 | $0.00 | 464,169 | D | — | — |